Full Text View
Tabular View
No Study Results Posted
Related Studies
Exploring the Role of 3T MRI in Gamma Knife Radiosurgery
This study is currently recruiting participants.
Study NCT00602992   Information provided by University Health Network, Toronto
First Received: September 19, 2007   Last Updated: January 9, 2009   History of Changes

September 19, 2007
January 9, 2009
August 2006
 
 
 
Complete list of historical versions of study NCT00602992 on ClinicalTrials.gov Archive Site
 
 
 
Exploring the Role of 3T MRI in Gamma Knife Radiosurgery
Exploring the Role of 3T MRI in Gamma Knife Radiosurgery: A Pilot Study

Gamma Knife radiosurgery is a non-invasive technique for the delivery of a single, high dose of radiation to an intra-cranial target. MRI has an established and central role in the treatment planning process and assessment of response to intracranial radiosurgery. Increasing the field strength of MRI from 1.5T to 3T promises to improve the signal, and in turn the quality of images. However, the technology also introduces new limitations, and the role and safety of 3T MRI in the management of patients receiving radiosurgery has not yet been reported. In this pilot study, we will explore the spatial integrity, and incremental image-guidance utility of 3T MRI in patients receiving radiosurgery. The preliminary data acquired in this study will be instrumental to the judicious design and conduct of subsequent definitive clinical trials. Up to fifty patients will be enrolled in this study.

 
 
Observational
Cohort, Cross-Sectional
Brain Metastases
 
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
50
 
 

Inclusion Criteria:

  • Patients planned to receive Gamma Knife radiosurgery will be eligible for enrollment on this study.

Exclusion Criteria:

  • Age<18
  • Contra-indications to 3T MRI, such as implanted metal devices or shrapnel.
Both
18 Years and older
No
Contact: Heather A Sharpe, B.Sc. 416-946-4501 ext 3427 heather.sharpe@uhn.on.ca
Canada
 
NCT00602992
Dr. Cynthia Menard, University Health Network
06-0427-CE
University Health Network, Toronto
 
Principal Investigator: Cynthia Menard, MD University Health Network, Toronto
University Health Network, Toronto
September 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP